Short-course therapy for acute sinusitis: How long is enough?

Treatments in Respiratory Medicine

Volumn 3, Issue 5, 2004, Pages 269-277

  Elies, Wolfgang ^a   Huber, Kora ^a  

^a OWL University   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAMASE INHIBITOR; CEFACLOR; CEFALEXIN; CEFETAMET PIVOXIL; CEFIXIME; CEFPODOXIME PROXETIL; CEFPROZIL; CEFTIBUTEN; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; CLAVULANIC ACID; ERYTHROMYCIN; GATIFLOXACIN; GEMIFLOXACIN; KETOLIDE; LEVOFLOXACIN; LORACARBEF; MACROLIDE; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROXITHROMYCIN; TELITHROMYCIN; TROVAFLOXACIN; UNINDEXED DRUG;

ACUTE DISEASE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIUM ISOLATION; BRAIN ABSCESS; CAVERNOUS SINUS THROMBOSIS; CHRONIC SINUSITIS; CLINICAL TRIAL; COMMON COLD; DRUG COST; DRUG EFFICACY; DRUG HALF LIFE; DRUG RESEARCH; EARLY DIAGNOSIS; EMPIRICISM; FRONTAL SINUSITIS; HAEMOPHILUS INFLUENZAE; HUMAN; INFLAMMATION; MAXILLA SINUSITIS; MEDICAL DECISION MAKING; MEDICAL SOCIETY; MEDICAL SPECIALIST; MORAXELLA CATARRHALIS; NOSE CONGESTION; PARANASAL SINUSITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SHORT COURSE THERAPY; SINUSITIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SUBDURAL EMPYEMA; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; DRUG ADMINISTRATION SCHEDULE; HUMANS; RANDOMIZED CONTROLLED TRIALS; SINUSITIS;

EID: 11044236813     PISSN: 11763450     EISSN: None     Source Type: Journal    
DOI: 10.2165/00151829-200403050-00001     Document Type: Review

References (63)

1. Stefansson P, Jacovides A, Jablonicky P, et al. Cefuroxime axetil versus clarithromycin in the treatment of acute maxillary sinusitis. Rhinology 1998; 36: 173-8
2. Gwaltney JM. Acute community-acquired sinusitis. Clin Infect Dis 1996; 23: 1209-25
3. Vital and Health Statistics. National Ambulatory Medical Care Survey. Rockville (MD): US Dept of Health and Human Services, 1994: 1777
4. Dingle JH, Badger GF, Jordan Jr WS. Illness in the home: a study of 25,000 illnesses in a group of Cleveland families. Cleveland (OH): Western Reserve University Press, 1964: 347
5. Baz MN, Jannetti W, Pause C. The efficacy and tolerability of moxifloxacin compared to trovafloxacin in the treatment of acute sinusitis. Todays Therapeutic Trends 1999; 17 (4): 303-19
6. Guay DR. Short-course antimicrobial therapy for upper respiratory tract infections. Clin Ther 2000 Jun; 22 (6): 673-84
7. Pichichero ME. Short course antibiotic therapy for respiratory infections: a review of the evidence. Pediatr Infect Dis J 2000; 19 (9): 929-37
8. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 1997; 117 Suppl. 2: 1-57
9. Hadley JA, Schaefer SD. Clinical evaluation of rhinosinusitis: history and physical examination. Otolaryngol Head Neck Surg 1997; 117 Suppl Pt 2: 8-12
10. Elies W. Clinical ENT-infections. 1st rev. ed. [in German]. Bremen: UNI-MED Verlag, 1999
11. Vogel F, Worth H, Adam D, et al. Rationale therapie bakterieller Atemwegsinfektionen. Empfehlungen einer Expertengruppe der Paul-Ehrlich-Gesellschaft für Chemotherapie und der Deutschen Atemwegsliga. Chemotherapie J 2000; 9 (1): 3-23
12. Elies W. Short term therapy with cefuroxime axetil for 5 days versus 10-day therapy with clarithromycin in acute sinusitis [in German]. Chemother J 2001; 10 (3): 105-9
13. Gwaltney Jr JM, Scheld WM, Sande MA, et al. The microbial etiology and antimicrobial therapy of adults in acute community sinusitis: a fifteen-year experience at the university of Virginia and review of other selected studies. J Allergy Clin Immunol 1992; 90: 457-62
14. Brook I. Bacteriology of chronic maxillary sinusitis in adults. Ann Otol Rhinol Laryngol 1989; 98 (6): 426-8
15. Williams Jr JW, Simel D, Roberts L, et al. Clinical evaluation for sinusitis: making the diagnosis by history and physical examination. Ann Intern Med 1992; 117: 705-10
16. Schuller DE, Schleuning II AJ. Otolaryngology: head and neck surgery. 8th ed. St Louis (MI): Mosby, 1993
17. Burke T, Villanueva C, Mariano H, et al. Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Clin Ther 1999; 21 (10): 1664-77
18. Wald ER. Acute sinusitis in children. Pediatr Infect Dis J 1988; 7: 150-5
19. Rees RE, Betts FB. A practical approach to infectious diseases. 3rd rev. ed. Boston (MA): Little, Brown and Company, 1994
20. Bottiglieri MT, Bistoni A. Evaluation of nasal discharge (NS) for bacterial sinusitis (BS) diagnosis [abstract D126]. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy; 2002 Sep 27-30; San Diego
21. O'Brian KL, Dowell SS, Schwartz B, et al. Acute sinusitis: principles of judicious use of antimicrobial agents. Pediatrics 1998; 101: 174-7
22. Arnold W, Ganzer U. Hals-Nasen-Ohren-Heilkunde. 2nd rev. ed. Stuttgart: Thieme, 1997
23. Höffler D, Shah P. C-reaktives Protein. 1st rev. ed. Stuttgart: Thieme, 1997
24. Jork K. Hals-Nasen-Ohreninfektionen. Forschung und Praxis 1995; 191: 3
25. Debreuil C, Gehanno P, Goldstein F, et al. Treatment of acute maxillary sinusitis in adult outpatients: comparison of a five versus ten day course of cefuroxime axetil. Med Malad Infect 2001; 31 (2): 70-8
26. Casiano PR. Azithromycin and amoxicillin in the treatment of acute maxillary sinusitis. Am J Med 1991; 91 Suppl. 3A: 27-30
27. Rolinson GN. A review of the microbiology of amoxicillin-clavulanic acid over the 15 year period 1978-1993. J Chemother 1994; 6: 238-318
28. Doern GV, Brueggemann AB, Pierce G, et al. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase positive strains resistant to amoxicillin-clavulanate: results of a national multicenter study. Antimicrob Agents Chemother 1997; 41: 292-7
29. Vogel F, Scholz H. Recommendations by the Paul-Ehrlich-Society for Chemotherapy for rational oral antibiotic therapy in adults [in German]. Chemother J 2002; 11 (2): 47-8
30. Seggev JS, Enrique RR, Brandon ML, et al. A combination of amoxicillin and clavulanate every 12 hours vs every 8 hours for treatment of acute bacterial maxillary sinusitis. Arch Otolaryngol Head Neck Surg 1998; 124 (8): 921-5
31. Adelglass J, DeAbate CA, McElvaine P, et al. Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults. Otolaryngol Head Neck Surg 1999; 120 (3): 320-7
32. Rakkar S, Roberts K, Towe BF, et al. Moxifloxacin versus amoxicillin-clavulanate in the treatment of acute maxillary sinusitis: a primary care experience. Int J Clin Pract 2001; 55 (5): 309-15
33. Tellier G, Lasko B, Leroy B, et al. Oral telithromycin (HMR 3647 800mg od) for 5 days and 10 days is well tolerated and as effective as amoxicillin/clavulanic acid (500/125mg tid) for 10 days in acute maxillary sinusitis (AMS) in adults. Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy; 2000 Sep 17-20; Toronto
34. Henry DC, Sydnor A, Settipane GA, et al. Comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of acute bacterial sinusitis. Clin Ther 1999; 21 (7): 1158-70
35. Gehanno P, Beauvillain C, Bobin S, et al. Short therapy with amoxicillin-clavulanate and corticosteroids in acute sinusitis: results of a multicenter study in adults. Scand J Infect Dis 2000; 32 (6): 679-84
36. Camacho AE, Cobo R, Otte J, et al. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis. Am J Med 1992; 93: 271-6
37. Sterkers O. Efficacy and tolerability of ceftibuten versus amoxicillin/clavulanate in the treatment of acute sinusitis. Chemotherapy 1997; 43 (5): 352-7
38. Adelglass J, Jones TM, Ruoff G, et al. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis. Pharmacotherapy 1998; 18 (6): 1255-63
39. Namyslowski G, Misiolek M, Malafiej E, et al. Randomized clinical trial comparing the efficacy and safety of Augmentin® versus cefuroxime in the treatment of chronic sinusitis in adult patients. Med Sci Monitor 1998; 4 (3): 551-4
40. Chow J, Russell M, Volk S, Chou C. Efficacy of cefditoren pivoxil (CDTR) vs amoxicillin/clavulanate (AMX/CLV) in acute maxillary sinusitis (AMS). Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy; 2000 Sep 17-20; Toronto
41. Gehanno P, Boucot I, Chiche D, et al. Treatment of community-acquired acute sinusitis: cefuroxime axetil vs cefixime. Med Mal Infect 1991; 21: 61-5
42. Lasko B, Lau CY, Saint-Pierre C, et al. Efficacy of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. The Canadian Sinusitis Study Group. J Int Med Res 1998; 26 (6): 281-91
43. Dubois J, Siant-Pierre C, Tremblay C. Efficacy of clarithromycin vs amoxicillin-clavulanate in treatment of acute maxillary sinusitis. Ear Nose Throat J 1993; 72: 1-4
44. Appelbaum PC. The Alexander project: worldwide development of antibacterial resistance in Streptococcus pneumoniae [letter]. Infection 2001; 29 Suppl. 1: 20
45. Reinert RR, Hoban DJ, Felminham D, et al. Worldwide surveillance of antibiotic resistance among clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes during 1999/2000 [abstract C2-692]. 41st Interscience Conference on Antimicrobial Agents and Chemotherapy; 2001 Dec 16-19; Chicago
46. Reinert RR, Luetticken R, Briefs C, et al. Antibiotic resistance of Streptococcus pyogenes and Streptococcus pneumoniae strains isolated from RTI outpatients in Germany, 2000-2001 [abstract C2-693]. 41st Interscience Conference on Antimicrobial Agents and Chemotherapy; 2001 Dec 16-19; Chicago
47. Roos K, Brunswick-Pitschner C, Kostrica R, et al. Efficacy and tolerability of once-daily therapy with telithromycin for 5 or 10 days for the treatment of acute maxillary sinusitis. Chemotherapy 2002; 48 (2): 100-8
48. Adam D, Scholz H, Helmerking M. Short course antibiotic treatment of 4782 culture proven cases of group A streptococcal tonsillopharyngitis and incidence of poststreptococcal sequelae. J Infect Dis 2000; 182: 509-16
49. Sabater F, Larrosa F, Guirao M, et al. Cefpodoxime proxetil vs amoxicillin/clavulanic acid in the treatment of acute maxillar-ethmoidal sinusitis in adult outpatients. 19th International Congress of Chemotherapy; 1995 Jul 16-21; Montreal
50. Khong TK. Shortened therapies in acute sinusitis. Hosp Pract 1996; 31 Suppl. 1: 11-8
51. Pessey J, Dubreuil C, Gehanno P, et al. Efficacité et tolerance du cefixime en traitement de 4 jours ou de 10 jours versus 10 jours d'amoxicillin-acide clavulanique dans les sinusitis aigues de I'adulte. Med Mal Infect 1996; 26: 889-945
52. Sher LD, McAdoo MA, Bettis RB, et al. A multicenter, randomized, investigator-blinded study of 5- and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis. Clin Ther 2002; 24 (2): 269-81
53. Anon JB, Seltzer EG. Effective 5-day, short course gemifloxacin therapy of acute bacterial sinusitis. Int J Antimicrob Agents 2001; 17 Suppl.: 67-8
54. Pichichero ME, Cohen R. Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis. Pediatr Infect Dis J 1997; 16: 680-95
55. Hoberman A, Paradise JL, Burch DJ, et al. Equivalent efficacy and reduced recurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for the treatment of otitis media in children. Pediatr Infect Dis J 1997; 16: 463-70
56. Gehanno P, Taillebe M, Denis P, et al. Short-course cefotaxime compared with 5-day co-amoxiclav in acute otitis media in children. J Antimicrob Chemother 1990; 26 Suppl. A: 29-36
57. Gooch WM, Blair E, Puopolo A, et al. Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media. Pediatr Infect Dis J 1996; 15: 157-64
58. Guillemot D, Carbon C, Balkau B, et al. Low dosage and long treatment duration of beta-lactams: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 1998; 279: 865-70
59. Mehra S, van Moerkerke M, Welck J, et al. Short course therapy with cefuroxime axetil for group A streptococcal tonsillopharyngitis in children. Pediatr Infect Dis J 1998; 17: 452-7
60. Cherry JD, Dudley JP. Sinusitis. In: Feigin RD, Cherry JD, editors. Textbook of pediatric infectious diseases. 3rd ed. Philadelphia (PA): WB Saunders Co, 1992: 142-8
61. Gwaltney Jr JM. Sinusitis. In: Mandell GL, Douglas Jr RG, Bennett JE, editors. Principles and practice of infectious diseases. 4th ed. Vol 1. New York: Churchill Livingstone, 1995: 585-90
62. Pessey JJ, Gehanno P, Thoroddsen E, et al. Short course therapy with cefuroxime axetil for acute otitis media: results of a randomized multicenter comparison with amoxicillin/clavulanate. Pediatr Infect Dis J 1999; 18: 854-9
63. Adam D, Scholz H, Helmerking M. Comparison of short-course cefuroxime axetil with a standard 10-day oral penicillin V regimen in the treatment of tonsillopharyngitis. J Antimicrob Chemother 2000; 45 Suppl.: 23-30